EUVIMEDEUVIMED entdecken
Leitlinie

Cost implications & Clinical Prudence in Managing Chronic Coronary Syndromes post ESC-Guidelines

David KL Quek

ASEAN Heart Journal · 2020

DOI: 10.31762/ahj2027.0102 ↗

Kurz gefasst

Leitlinie in der Zeitschrift ASEAN Heart Journal, 2020. Verfasst von David KL Quek.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Syndromes post ESC-GuidelinesStable angina or stable coronary artery disease has now been redefined as chronic coronary syndromes (CCS) partly to be more inclusive for several hitherto under-represented, under-recognised non-obstructive coronary artery entities that present as angina-like or myocardial ischemic syndromes.1

Zitieren

APA

Quek, D. K. (2020). Cost implications & Clinical Prudence in Managing Chronic Coronary Syndromes post ESC-Guidelines. ASEAN Heart Journal. https://doi.org/10.31762/ahj2027.0102

Vancouver

Quek DK. Cost implications & Clinical Prudence in Managing Chronic Coronary Syndromes post ESC-Guidelines. ASEAN Heart Journal. 2020. doi:10.31762/ahj2027.0102

BibTeX
@article{Quek2020,
  author = {Quek, David KL},
  title = {Cost implications & Clinical Prudence in Managing Chronic Coronary Syndromes post ESC-Guidelines},
  journal = {ASEAN Heart Journal},
  year = {2020},
  doi = {10.31762/ahj2027.0102}
}
Kostenlos starten →